LXU · Lsb Industries, Inc.
Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted EBITDA non-GAAP | $52M | Q1 2026 call | +79.3% |
|
|
|||
| free cash flow | $37M | Q1 2026 call | — |
| net leverage | 1.4 | Q1 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LXU
this stock
Lsb Industries, Inc.
|
$819.19M | +34.0% | -34.2% | 18.1 | 4.3% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$85.04B | +44.2% | — | — | 0.3% |
|
DOW
Dow Inc.
|
$21.56B | +29.5% | -7.0% | — | 4.8% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$16.10B | +25.7% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.01B | +8.2% | -7.1% | — | 7.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LXU | +4.4% | -2.8% | +15.3% | +5.4% | +34.0% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | +5.9% | -3.1% | +7.4% | +5.8% | +25.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.